Chemed Corp (CHE)

CHE (NYSE:Health Services)
$103.39
pos +0.83
+0.81%
Today's Range: 102.00 - 103.51 | CHE Avg Daily Volume: 224,700
Last Update: 08/21/14 - 4:02 PM EDT
Volume: 148,930
YTD Performance: 33.86%
Open: $102.78
Previous Close: $102.56
52 Week Range: $64.16 - $103.50
Oustanding Shares: 17,287,284
Market Cap: 1,778,515,778
6-Month Chart
TheStreet Ratings Grade for CHE
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 2 2 2 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.33 2.33 2.33 2.00
Latest Dividend: 0.22
Latest Dividend Yield: 0.86%
Dividend Ex-Date: 08/14/14
Price Earnings Ratio: 21.89
Price Earnings Comparisons:
CHE Sector Avg. S&P 500
21.89 21.90 28.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
16.64% 43.20% 91.06%
GROWTH 12 Mo 3 Yr CAGR
Revenue -1.20 0.10 0.03
Net Income -13.50 -0.06 -0.02
EPS -10.00 0.17 0.05
Earnings for CHE:
EBITDA 0.19B
Revenue 1.41B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.34 $1.51 $5.34 $5.79
Number of Analysts 1 1 1 1
High Estimate $1.34 $1.51 $5.34 $5.79
Low Estimate $1.34 $1.51 $5.34 $5.79
Prior Year $1.31 $1.40 $5.42 $5.34
Growth Rate (Year over Year) 2.29% 7.86% -1.48% 8.43%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Roger Arnold

 | Mar 5, 2013 | 6:00 PM EST

Companies that provide end-of-life services have demographics on their side.

bullishChemed Corporation target raised at Oppenheimer

Feb 20, 2013 | 8:09 AM EST

Shares of CHE now seen reaching $91, Oppenheimer said. Fourth quarter beat. Outperform rating.

bullishChemed Corporation target raised at Oppenheimer

Oct 3, 2012 | 8:39 AM EDT

Shares of CHE now seen reaching $80, Oppenheimer said. Bullish following management meetings. Outperform rating.

By

Roger Arnold

 | Apr 19, 2012 | 4:30 PM EDT

These stocks stand to benefit if Americans can accept the fact that rising health care costs aren't magically going away.

By

Paul Price

 | Nov 18, 2011 | 9:00 AM EST

Recently accused of Medicare fraud, Chemed is facing costly legal problems.

By

Roger Arnold

 | Oct 20, 2011 | 4:00 PM EDT

Financial pain caused by a flat yield curve will cascade from the insurance industry into health care.

By

John Reese

 | Sep 6, 2011 | 3:00 PM EDT

If only the entire economy felt as well.

TWTR is trading $45.00, down small with IV30™ down 1.6%. Conclusion The future risk...
EBAY is the top gainer in the Nazz 100 today following news of a potential PayPal sp...

What's Trading in the Option Market

Notable One-day Option Position Increases

IRF ...
As $MA continues to hold above key daily support, we can look at the 1st potential upside ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.